United States · Markets & Finance · The Motley Fool

AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

Published by The Motley Fool · United States 8 h ago

Earlier this week, the U.S. Food and Drug Administration (FDA) approved AbbVie 's ( ABBV +1.11%) Juvmo (tavapadon). This is a once-daily pill for adults with Parkinson's disease…

Read the full article on The Motley Fool Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Benzinga

Top Performing Stocks

Business Insider

Ramp's Broadway musical was the worst show I've ever seen. I'm still glad it exists.

Quartz

10 U.S. cities where it takes the biggest paycheck to buy a home

NYT Business

Trump Says Economy Has ‘Public Relations’ Problem Amid High Prices and Slow Hiring

CNBC

America’s data center fight is a preview of what's to come for the rest of the world

TheStreet